Biognosys and Michael J. Fox Foundation Partner to Develop Parkinson’s Disease Biomarkers
The collaboration focuses on creating sensitive assays for a common genetic risk factor to guide drug development and clinical trials.
Tag: biomarkers
All
Latest
All
Latest
Concussion Blood Test Advances Toward FDA Submission With Point-of-Care Collaboration
BRAINBox Solutions reports near-completion of its HeadSMART II trial for a concussion blood test, supporting an upcoming FDA submission, and advances in a point-of-care biomarker collaboration with Prolight Diagnostics.
All
Latest
Roche Receives CE Mark for Blood-Based Immunoassay Test to Detect Alzheimer’s Genetic Risk Factor ApoE4
The test identifies carriers of a genetic variant found in up to 60% of Alzheimer's patients, helping clinicians triage patients and guide treatment decisions.
Circular Genomics Secures Exclusive Rights to Blood Test Technology for Alzheimer’s Disease
Circular Genomics has secured exclusive rights from Washington University and Max Delbrück Center to develop a blood-based Alzheimer’s test using circular RNA biomarkers.
Read More
PathAI Launches AI Tools for Inflammatory Bowel Disease Clinical Trials
PathAI has launched new AI-powered tools on its AISight Clinical Trials Platform, providing standardized histopathology endpoints for inflammatory bowel disease drug development.
Read More
Blood Test Detects Early-Stage Cancer Using DNA Methylation Patterns
Johns Hopkins researchers have developed a liquid biopsy that detects early-stage lung and breast cancers by measuring DNA methylation variation, showing high accuracy in a study published in Clinical Cancer Research.
Read More
New Test Strip Detects Cancer Biomarkers at Ultra-Low Concentrations
Researchers at La Trobe University have developed a single-use test strip that detects cancer-related microRNAs in blood plasma at concentrations up to 1,000 times lower than current methods.
Read More
Blood Test Identifies Lung Cancer Patients Who Will Respond to Immunotherapy
Researchers at Mass General Brigham have developed a blood test that predicts tarlatamab response in small cell lung cancer, showing 85% sensitivity and 100% specificity.
Read More
Researchers Identify Four New Markers for Detecting Aggressive Breast Cancer Cells in Blood
Researchers at Baylor College of Medicine have identified four new protein markers that improve detection of triple-negative breast cancer cells in blood, potentially enhancing the accuracy of liquid biopsy tests, according to a recent study.
Read More
Finger Prick Blood Test for Alzheimer’s Diagnosis Enters Large-Scale Trial
A large-scale international trial is evaluating a finger prick blood test for Alzheimer’s, analyzing three protein biomarkers as a potential alternative to PET scans and lumbar punctures.
Read More
New Blood Test Signature Could Improve Type 2 Diabetes Risk Prediction
A 44-metabolite blood test signature identified by Mass General Brigham and Einstein researchers improved type 2 diabetes risk prediction in a study of over 23,000 participants, according to Nature Medicine.
Read More
What Clinical Lab Leaders Predict for 2026
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Read More
Neurogen Biomarking Partners with Tasso for Needle-Free Blood Collection in Alzheimer’s Testing
The collaboration aims to make home-based Alzheimer’s biomarker testing more accessible through virtually painless blood collection technology.
Read More
New FDA-Cleared Blood Test Moves Alzheimer’s Assessment into Primary Care
Roche’s Elecsys pTau181 assay gives clinical labs a key role in the initial evaluation of cognitive decline, helping to rule out amyloid pathology earlier in the diagnostic process.
Read More
Study Demonstrates Accuracy of Two Quest Blood Tests for Alzheimer’s Diagnosis
Two biomarker panels demonstrated 91% sensitivity and specificity in symptomatic patients, potentially reducing the need for PET imaging confirmation.
Read More
AI Platform Adds Nutrition Integration to Lab Result Interpretation
BloodGPT’s new feature provides biomarker-based nutrition plans alongside automated lab result analysis for clinical laboratories.
Read More
Lunit and Agilent Partner to Develop AI-Powered Companion Diagnostics
The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read More
Korean Researchers Develop SERS Platform 100,000 Times More Sensitive Than ELISA for Alzheimer’s Detection
The surface-enhanced Raman spectroscopy platform can detect amyloid beta biomarkers at ultra-low concentrations in body fluids, potentially enabling earlier diagnosis and monitoring of disease progression.
Read More